keyword
https://read.qxmd.com/read/35531117/predictors-of-hyperkalemia-after-total-parathyroidectomy-in-patients-with-drug-refractory-secondary-hyperparathyroidism
#21
JOURNAL ARTICLE
Xi Zhu, Zhouting Li, Xiaofang Xia, Xiaomin Zeng, Feng Cheng, Bin Zhou, Yong Wu, Lei Zhu
Background: The purpose of this retrospective study was to explore the primary possible risk factors for the development of postoperative hyperkalemia after total parathyroidectomy with autotransplantation (TPTX + AT) in patients with drug-refractory secondary hyperparathyroidism (SHPT). Methods: The clinical data of 149 patients receiving maintenance dialysis for drug-refractory SHPT, who underwent TPTX + AT, were reviewed and analyzed. Demographic data, dialysis status, and laboratory test indices were collected from enrolled patients...
April 2022: Gland Surgery
https://read.qxmd.com/read/35520368/two-cases-of-brash-syndrome-a-diagnostic-challenge
#22
JOURNAL ARTICLE
Parthav Shah, Krixie Silangruz, Eric Lee, Yoshito Nishimura
Bradycardia, renal failure, atrioventricular (AV) nodal blockade, shock, and hyperkalemia (BRASH) syndrome is a relatively new clinical entity. It is often underrecognized, underdiagnosed, and confused with other causes of bradycardia. Treatment of BRASH syndrome differs from the standard bradycardia algorithm in advanced cardiac life support (ACLS), and the cornerstone management remains treating the hyperkalemia, improving renal function by treating the underlying cause, withholding AV nodal blocking agents, and considering dialysis in refractory cases, as any single factor could precipitate the vicious cycle...
2022: European Journal of Case Reports in Internal Medicine
https://read.qxmd.com/read/35371852/pseudohyperkalemia-in-a-patient-with-chronic-lymphocytic-leukemia
#23
Rahul Gujarathi, Venu Chippa, Narsimha Candula, Meet Kadakia
Hyperkalemia is a common electrolyte disorder with potentially life-threatening consequences, including cardiac dysrhythmias. Pseudohyperkalemia must always be ruled out before implementing treatment for true hyperkalemia. Here, we present a case of a 63-year-old male with chronic lymphocytic leukemia (CLL) with a white blood cell count greater than 200 thousand/mm3 and persistently high serum potassium concentration as high as 8.4 mmol/L. A venous blood gas analysis was performed, which confirmed the patient's plasma potassium levels were within the normal range (3...
March 2022: Curēus
https://read.qxmd.com/read/35094636/a-single-center-experience-of-parathyroidectomy-in-1500-cases-for-secondary-hyperparathyroidism-a-retrospective-study
#24
JOURNAL ARTICLE
Shasha Zhao, Wei Gan, Wenjia Xie, Jinlong Cao, Liang Zhang, Ping Wen, Junwei Yang, Mingxia Xiong
BACKGROUND: Chronic kidney disease (CKD) is a global public health problem. With the deterioration of renal function, a certain proportion of CKD patients enter the uremic stage, and secondary hyperparathyroidism (SHPT) becomes a challenge. For refractory hyperparathyroidism, parathyroidectomy (PTX) plays a key role in reducing mortality and improving prognosis. Nevertheless, no consensus has been reached on the optimal surgical method. We aimed to provide evidence for the effectiveness of surgical treatment by summarizing the experience from our center...
December 2022: Renal Failure
https://read.qxmd.com/read/35058422/brash-syndrome-a-case-report
#25
JOURNAL ARTICLE
José João Bailuni Neto, Bernardo de Lima Siqueira, Fernando Chiodini Machado, Gustavo André Boeing Boros, Marco Alexander Valverde Akamine, Leonardo Jorge Cordeiro de Paula, Arthur Cicupira Rodrigues de Assis, Paulo Rogério Soares, Thiago Luis Scudeler
BACKGROUND BRASH syndrome is a newly recognized clinical entity characterized by bradycardia, renal failure, atrioventricular blockade, shock, and hyperkalemia. Patients with BRASH syndrome often have severe bradycardia that is refractory to antidotes and chronotropic medications. In these situations, transvenous pacemaker and renal replacement therapy may be necessary. Therefore, rapid diagnosis and correct management of this entity are crucial to reduce mortality. We report a case and the management of BRASH syndrome in the Emergency Department...
January 21, 2022: American Journal of Case Reports
https://read.qxmd.com/read/34930851/a-review-on-the-possible-pathophysiology-of-potassium-abnormalities-in-covid-19
#26
REVIEW
Maryam Noori, Seyed Aria Nejadghaderi, Mark J M Sullman, Kristin Carson-Chahhoud, Mohammadreza Ardalan, Ali-Asghar Kolahi, Saeid Safiri
Coronavirus disease 2019 (COVID-19) is a catastrophic contagious disease caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). Electrolyte disturbances are common complications of COVID-19. The present article examined the potential mechanisms of hypokalemia and hyperkalemia in patients suffering from COVID-19, in order to raise awareness of potassium disorders in SARS-CoV-2 infections. PubMed, Scopus, and Google Scholar were searched with keywords, such as "COVID-19", "SARS-CoV-2", "2019-nCoV", "Hypokalemia", "Hyperkalemia", "Serum potassium", and "Etiology", "Pathophysiology" up to April 20, 2021 without any search filters...
December 2021: Iranian Journal of Kidney Diseases
https://read.qxmd.com/read/34904781/use-of-extracorporeal-therapy-in-a-dog-with-heatstroke
#27
Alyx Tracy, Alex Lynch, Kristen Messenger, Shelly Vaden, Alessio Vigani
OBJECTIVE: To describe the use of extracorporeal therapy (ECT) in the management of a dog with complications stemming from heatstroke. CASE REVIEW: A 3-year-old intact male Rhodesian Ridgeback was presented for heat-related illness following strenuous exercise. Despite intensive supportive care, the dog developed progressive and refractory hyperkalemia, hypoglycemia, neurologic dysfunction, acute kidney injury (AKI), and pulmonary dysfunction. Four ECT sessions were performed in this dog, consisting of 4 intermittent hemodialysis (HD) sessions, the first 2 of which concurrently utilized hemoperfusion with a cytokine adsorption filter...
July 2022: Journal of Veterinary Emergency and Critical Care
https://read.qxmd.com/read/34740043/the-role-of-potassium-in-muscle-membrane-dysfunction-in-end-stage-renal-disease
#28
JOURNAL ARTICLE
Lotte Hardbo Larsen, Werner J Z'Graggen, Hugh Bostock, S Veronica Tan, Niels Henrik Buus, Hatice Tankisi
OBJECTIVE: Uremic myopathy is a condition seen in end-stage renal disease (ESRD), characterized by muscle weakness and muscle fatigue, in which the pathophysiology is uncertain. The aim of this study was to assess the role of abnormal serum constituents in ESRD patients by relating them to the excitability properties of the tibialis anterior muscle, at rest and during electrically induced muscle activation, by recording muscle velocity recovery cycles (MVRC) and frequency ramp responses...
December 2021: Clinical Neurophysiology: Official Journal of the International Federation of Clinical Neurophysiology
https://read.qxmd.com/read/34414500/monogenic-forms-of-low-renin-hypertension-clinical-and-molecular-insights
#29
JOURNAL ARTICLE
Priyanka Khandelwal, Jaap Deinum
Monogenic disorders of hypertension are a distinct group of diseases causing dysregulation of the renin-angiotensin-aldosterone system and are characterized by low plasma renin activity. These can chiefly be classified as causing (i) excessive aldosterone synthesis (familial hyperaldosteronism), (ii) dysregulated adrenal steroid metabolism and action (apparent mineralocorticoid excess, congenital adrenal hyperplasia, activating mineralocorticoid receptor mutation, primary glucocorticoid resistance), and (iii) hyperactivity of sodium and chloride transporters in the distal tubule (Liddle syndrome and pseudohypoaldosteronism type 2)...
August 20, 2021: Pediatric Nephrology
https://read.qxmd.com/read/34292479/mechanisms-and-management-of-drug-induced-hyperkalemia-in-kidney-transplant-patients
#30
REVIEW
John G Rizk, Jose G Lazo, David Quan, Steven Gabardi, Youssef Rizk, Elani Streja, Csaba P Kovesdy, Kamyar Kalantar-Zadeh
Hyperkalemia is a common and potentially life-threatening complication following kidney transplantation that can be caused by a composite of factors such as medications, delayed graft function, and possibly potassium intake. Managing hyperkalemia after kidney transplantation is associated with increased morbidity and healthcare costs, and can be a cause of multiple hospital admissions and barriers to patient discharge. Medications used routinely after kidney transplantation are considered the most frequent culprit for post-transplant hyperkalemia in recipients with a well-functioning graft...
December 2021: Reviews in Endocrine & Metabolic Disorders
https://read.qxmd.com/read/34242687/minimal-change-disease-with-severe-acute-kidney-injury-following-the-oxford-astrazeneca-covid-19-vaccine-a-case-report
#31
Simon Leclerc, Virginie Royal, Caroline Lamarche, Louis-Philippe Laurin
We report a case of minimal change disease (MCD) with severe acute kidney injury (AKI) following the first injection of the ChAdOx1 nCoV-19 (AZD1222) vaccine from Oxford-AstraZeneca against coronavirus disease 2019 (COVID-19). A 71-year-old man with a history of dyslipidemia and a baseline serum creatinine of 0.7mg/dL presented with nephrotic syndrome, AKI, and severe hypertension 13 days after receiving the Oxford-AstraZeneca vaccine. Refractory hyperkalemia and hypervolemia with oligoanuria prompted initiation of hemodialysis...
October 2021: American Journal of Kidney Diseases
https://read.qxmd.com/read/34213484/panhypopituitarism-in-acute-myocardial-infarction
#32
Ritwik Ghosh, Subhankar Chatterjee, Devlina Roy, Souvik Dubey, Carl J Lavie
While hypopituitarism is known to be associated with increased cardiovascular morbidity and mortality, panhypopituitarism as a complication of myocardial infarction (MI) is very rare. Here, we report a case of rapidly developing empty sella syndrome with florid manifestations of panhypopituitarism after MI (due to critical stenosis in the left anterior descending artery) complicated by cardiogenic shock in a 65-year-old man. The patient was initially stabilized with conservative management of non-ST-elevated MI and cardiogenic shock, but after initial improvement, he again deteriorated with refractory shock (not adequately responding to vasopressors), seizures, hypoglycemia, hyponatremia, hyperkalemia, and metabolic acidosis...
April 2021: Annals of African Medicine
https://read.qxmd.com/read/33640217/brash-syndrome-a-case-report
#33
JOURNAL ARTICLE
V K Vishnu, Nayer Jamshed, V T Amrithanand, Soumitra Thandar
BACKGROUND: BRASH syndrome, a relatively new entity, has been described in the recent literature. It is defined as a combination of bradycardia, renal failure, atrioventricular nodal blockade, shock, and hyperkalemia. Although it is apparent that clinical symptomatology includes shock, it is still unclear whether all patients will initially present with all five components mentioned in the BRASH acronym. CASE REPORT: An elderly woman presented to our Emergency Department (ED) with hyperkalemia, acute renal failure, and metabolic acidosis with bradycardia, which was refractory to antikalemic measures and atropine...
June 2021: Journal of Emergency Medicine
https://read.qxmd.com/read/33326148/spironolactone-in-adolescent-acne-vulgaris
#34
JOURNAL ARTICLE
Rachita Dhurat, Deepti Shukla, Rachel K Lim, Carlos G Wambier, Andy Goren
Acne vulgaris (AV) is the most common skin condition affecting adolescents, most likely due to elevated androgen levels during puberty. Androgens stimulate and enlarge the sebaceous glands and keratinocytes, resulting in increased production of sebum and abnormal hyperproliferation of keratinocytes which lead to the formation of acne lesions. Current standard of care for AV includes topical therapies for mild cases and antibiotics or oral retinoids for severe cases. In recent years, spironolactone, an aldosterone antagonist and diuretic, has been applied to the treatment of AV due to its anti-androgen effects...
January 2021: Dermatologic Therapy
https://read.qxmd.com/read/33133704/type-iv-rta-in-chronic-adrenal-insufficiency-and-concomitant-lisinopril-treatment
#35
Francesca Galbiati
Type IV renal tubular acidosis (RTA) is the only RTA characterized by hyperkalemia, and it is caused by a true aldosterone deficiency or renal tubular aldosterone hyporesponsiveness. It is frequent among hospitalized patients as it is related to type 2 diabetes mellitus (T2DM) and common medications such as ACE-inhibitors (ACE-is) and trimethoprim-sulfamethoxazole (TMP-SMX). Drug-induced RTA commonly manifests in patients with predisposing conditions such as mild renal insufficiency and certain pharmacological therapies...
2020: Case Reports in Endocrinology
https://read.qxmd.com/read/33086931/potential-consequences-of-the-red-blood-cell-storage-lesion-on-cardiac-electrophysiology
#36
JOURNAL ARTICLE
Marissa Reilly, Chantal D Bruno, Tomas M Prudencio, Nina Ciccarelli, Devon Guerrelli, Raj Nair, Manelle Ramadan, Naomi L C Luban, Nikki Gillum Posnack
Background The red blood cell (RBC) storage lesion is a series of morphological, functional, and metabolic changes that RBCs undergo following collection, processing, and refrigerated storage for clinical use. Since the biochemical attributes of the RBC unit shifts with time, transfusion of older blood products may contribute to cardiac complications, including hyperkalemia and cardiac arrest. We measured the direct effect of storage age on cardiac electrophysiology and compared it with hyperkalemia, a prominent biomarker of storage lesion severity...
November 3, 2020: Journal of the American Heart Association
https://read.qxmd.com/read/32709394/hyperkalemia-and-hypertension-post-organ-transplantation-a-management-challenge
#37
REVIEW
Seyed Mehrdad Hamrahian, Tibor Fülöp
Potassium is the most important intracellular cation and the kidneys play a pivotal role in potassium homeostasis. Potassium disorder is a common electrolyte abnormality and it increases the risk of death from any cause, particularly cardiovascular events. Hyperkalemia is a common electrolyte abnormality encountered post organ transplantation. The etiology is multifactorial, and includes drugs such as calcineurin inhibitors. In certain regards, the clinical picture of post-transplantation hyperkalemia and hypertension resembles that of Gordon syndrome or familial hyperkalemic hypertension, a disorder characterized by over activity of thiazide-sensitive sodium chloride cotransporter...
January 2021: American Journal of the Medical Sciences
https://read.qxmd.com/read/32602439/endocrine-and-metabolic-manifestations-of-snakebite-envenoming
#38
REVIEW
Saptarshi Bhattacharya, Aishwarya Krishnamurthy, Maya Gopalakrishnan, Sanjay Kalra, Viny Kantroo, Sameer Aggarwal, Vineet Surana
Snakebite envenoming is a neglected, public health problem in tropical and subtropical regions. Local tissue necrosis, neurotoxic, and hemo-vasculotoxic effects are well-recognized features, whereas the endocrine and metabolic derangements are not as well known. In addition to contributing to morbidity, some of these manifestations can be potentially life-threatening if not recognized early. The most prominent endocrine manifestation is hypopituitarism (HP), which can manifest acutely or remain asymptomatic and present years later...
October 2020: American Journal of Tropical Medicine and Hygiene
https://read.qxmd.com/read/32563818/amputation-in-crush-syndrome-a-case-report
#39
María Camila Arango-Granados, Diego Fernando Cruz Mendoza, Alexander Ernesto Salcedo Cadavid, Alberto Federico García Marín
INTRODUCTION: Crush syndrome (CS) is a condition with a high morbidity and mortality due to severe electrolyte disorders, circulatory dysfunction and multiple organ failure, secondary to severe rhabdomyolysis and reperfusion injuries. There is controversy about the role of fasciotomy in the treatment of compartment syndromes due to crush injuries and it is still unknown if early amputation has patient-centered benefits. CASE PRESENTATION: This is a 29-year-old patient whose lower body was trapped for 50 h under a 40-meter landslide...
2020: International Journal of Surgery Case Reports
https://read.qxmd.com/read/32492644/pentobarbital-induced-hypokalemia-a-worrying-sequela
#40
Mark Awad, Joyce Bonitz, Abimbola Pratt
INTRODUCTION: Intracranial hypertension that is not responsive to other therapies can be managed through the use of a barbiturate induced coma. Although potentially effective, there are known complications associated with this treatment, and as such it is typically reserved for the most severe cases. One such sequela of barbiturate induced coma therapy is refractory hypokalemia and subsequent rebound hyperkalemia. PRESENTATION OF CASE: This case report discusses a patient who experienced hypokalemia during pentobarbital induced coma for unmanageable elevations in intracranial pressure and was treated conservatively to avoid rebound hyperkalemia depicting successful deployment of permissive hypokalemia...
2020: International Journal of Surgery Case Reports
keyword
keyword
165017
2
3
Fetch more papers »
Fetching more papers... Fetching...
Remove bar
Read by QxMD icon Read
×

Save your favorite articles in one place with a free QxMD account.

×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"

We want to hear from doctors like you!

Take a second to answer a survey question.